RDNT
RadNet, Inc. NASDAQ Listed Jan 3, 1997$57.52
Mkt Cap $4.5B
52w Low $50.76
19.3% of range
52w High $85.84
50d MA $60.32
200d MA $69.49
P/E (TTM)
-227.4x
EV/EBITDA
26.6x
P/B
3.1x
Debt/Equity
1.7x
ROE
-1.7%
P/FCF
62.7x
RSI (14)
—
ATR (14)
—
Beta
1.53
50d MA
$60.32
200d MA
$69.49
Avg Volume
845.4K
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
1508, 1510 and 1516 Cotner Avenue · Los Angeles, CA 90025-3303 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.19 | 0.23 | +21.1% | 75.22 | -3.0% | -3.5% | -1.7% | -6.5% | -9.0% | +2.7% | — |
| Nov 9, 2025 | AMC | 0.22 | 0.20 | -10.3% | — | — | — | — | — | — | — | — |
| Aug 10, 2025 | AMC | 0.17 | 0.31 | +82.4% | — | — | — | — | — | — | — | — |
| May 11, 2025 | AMC | -0.17 | -0.35 | -105.9% | — | — | — | — | — | — | — | — |
| Feb 27, 2025 | AMC | 0.21 | 0.22 | +4.8% | 57.60 | -13.2% | -3.7% | -8.3% | +1.9% | +2.4% | -2.8% | — |
| Nov 10, 2024 | AMC | 0.14 | 0.18 | +32.5% | — | — | — | — | — | — | — | — |
| Aug 7, 2024 | AMC | 0.16 | 0.16 | +0.0% | 56.89 | +1.5% | +8.4% | +1.9% | -1.9% | +2.7% | -1.0% | — |
| May 8, 2024 | AMC | -0.09 | 0.07 | +177.8% | 50.63 | +0.8% | +5.8% | +3.1% | +0.9% | +1.8% | +2.7% | — |
| Feb 29, 2024 | AMC | 0.11 | 0.20 | +81.8% | 37.86 | +5.7% | +17.1% | +5.6% | +1.3% | +2.3% | +0.1% | — |
| Nov 8, 2023 | AMC | 0.06 | 0.14 | +133.3% | 28.72 | +3.3% | +2.6% | -1.0% | -1.3% | +9.7% | +2.4% | — |
| Aug 8, 2023 | AMC | 0.07 | 0.24 | +242.9% | 31.72 | +0.6% | -0.7% | +1.3% | -1.3% | +0.5% | +1.3% | — |
| May 9, 2023 | AMC | -0.07 | -0.08 | -14.3% | 28.56 | +1.1% | -1.1% | -4.4% | -0.1% | +2.7% | -0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 | Barclays | Maintains | Overweight → Overweight | — | $57.85 | $57.83 | -0.0% | -0.6% | +0.6% | -2.4% | +2.1% | +0.2% |
| Dec 1 | B. Riley Securities | Maintains | Buy → Buy | — | $82.79 | $82.25 | -0.7% | -3.4% | -1.5% | +0.8% | +2.0% | -3.1% |
| Nov 13 | Barclays | Maintains | Overweight → Overweight | — | $74.45 | $74.05 | -0.5% | -1.3% | +2.3% | +2.5% | +2.8% | +1.4% |
| Nov 12 | Truist | Maintains | Buy → Buy | — | $78.50 | $78.45 | -0.1% | -5.2% | -1.3% | +2.3% | +2.5% | +2.8% |
| Sep 3 | Barclays | Maintains | Overweight → Overweight | — | $70.31 | $71.44 | +1.6% | +0.9% | +1.9% | -1.2% | +0.8% | +1.5% |
| Sep 3 | Truist | Maintains | Buy → Buy | — | $70.31 | $71.44 | +1.6% | +0.9% | +1.9% | -1.2% | +0.8% | +1.5% |
| Aug 13 | Raymond James | Maintains | Strong Buy → Strong Buy | — | $63.60 | $64.45 | +1.3% | +7.6% | +0.5% | -1.9% | -1.7% | +2.5% |
| Apr 11 | Truist | Maintains | Buy → Buy | — | $53.00 | $52.75 | -0.5% | +0.8% | -0.1% | -0.5% | -4.8% | -1.5% |
| Mar 24 | Barclays | Maintains | Overweight → Overweight | — | $49.25 | $49.52 | +0.5% | +5.2% | -2.2% | +0.0% | -0.1% | -2.4% |
| Mar 5 | Raymond James | Upgrade | Outperform → Strong Buy | — | $51.83 | $52.25 | +0.8% | +2.4% | -2.8% | -2.5% | -4.5% | +2.5% |
| Jan 22 | Barclays | Maintains | Overweight → Overweight | — | $60.19 | $59.71 | -0.8% | +5.9% | +1.9% | -1.3% | -1.2% | +4.2% |
| Jan 22 | Truist | Maintains | Buy → Buy | — | $60.19 | $59.71 | -0.8% | +5.9% | +1.9% | -1.3% | -1.2% | +4.2% |
| Jan 15 | Jefferies | Maintains | Buy → Buy | — | $65.65 | $66.61 | +1.5% | -6.0% | -1.4% | -1.7% | +0.6% | +5.9% |
| Dec 5 | Jefferies | Maintains | Buy → Buy | — | $80.86 | $79.95 | -1.1% | -2.1% | +3.1% | -3.3% | +0.0% | +2.1% |
| Dec 4 | Barclays | Maintains | Overweight → Overweight | — | $80.64 | $81.29 | +0.8% | +0.3% | -2.1% | +3.1% | -3.3% | +0.0% |
| Nov 29 | Truist | Maintains | Buy → Buy | — | $82.49 | $84.24 | +2.1% | -0.9% | +1.3% | -2.7% | +0.3% | -2.1% |
| Sep 23 | Truist | Maintains | Buy → Buy | — | $69.34 | $70.00 | +1.0% | +2.5% | -1.8% | +1.5% | -2.6% | +0.4% |
| Sep 19 | Jefferies | Maintains | Buy → Buy | — | $67.11 | $69.32 | +3.3% | +3.8% | -0.4% | +2.5% | -1.8% | +1.5% |
| Sep 6 | Barclays | Upgrade | Equal Weight → Overweight | — | $63.19 | $65.79 | +4.1% | -1.2% | -2.5% | -0.8% | +3.2% | +7.9% |
| Aug 8 | Barclays | Maintains | Equal Weight → Equal Weight | — | $56.89 | $57.76 | +1.5% | +8.4% | +1.9% | -1.9% | +2.7% | -1.0% |
| Jul 15 | Truist | Maintains | Buy → Buy | — | $61.41 | $62.50 | +1.8% | +2.1% | +3.9% | -4.3% | -3.0% | +2.5% |
| Jul 11 | Jefferies | Maintains | Buy → Buy | — | $56.22 | $58.21 | +3.5% | +6.4% | +2.6% | +2.1% | +3.9% | -4.3% |
| Jul 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $56.69 | $57.15 | +0.8% | -0.8% | +6.4% | +2.6% | +2.1% | +3.9% |
| May 15 | Truist | Maintains | Buy → Buy | — | $56.73 | $57.38 | +1.1% | +2.7% | -1.1% | -0.2% | +1.8% | -0.4% |
| May 10 | Raymond James | Maintains | Outperform → Outperform | — | $53.57 | $53.82 | +0.5% | +3.1% | +0.9% | +1.8% | +2.7% | -1.1% |
| Mar 28 | Truist | Maintains | Buy → Buy | — | $48.49 | $48.91 | +0.9% | +0.4% | -1.1% | -0.2% | +0.1% | -0.3% |
| Mar 22 | Jefferies | Maintains | Buy → Buy | — | $47.17 | $47.25 | +0.2% | +1.8% | -2.1% | +2.7% | +0.4% | +0.4% |
| Mar 4 | Truist | Maintains | Buy → Buy | — | $44.35 | $44.95 | +1.4% | +5.6% | +1.3% | +2.3% | +0.1% | -4.2% |
| Dec 8 | Truist | Maintains | Buy → Buy | — | $36.02 | $36.66 | +1.8% | +0.6% | -0.4% | +0.7% | +2.3% | -0.5% |
| Jun 26 | Raymond James | Maintains | Outperform → Outperform | — | $33.44 | $33.36 | -0.2% | -2.0% | +0.9% | +0.6% | -0.8% | -1.1% |
| May 10 | Raymond James | Maintains | Outperform → Outperform | — | $28.56 | $28.87 | +1.1% | -1.1% | -4.4% | -0.1% | +2.7% | -0.3% |
| Mar 31 | CJS Securities | Maintains | Outperform → Outperform | — | $24.48 | $24.63 | +0.6% | +2.2% | +0.6% | -0.7% | +0.3% | +3.8% |
| Mar 3 | Raymond James | Upgrade | Market Perform → Outperform | — | $23.81 | $25.17 | +5.7% | +5.3% | -2.8% | +0.7% | -0.3% | -3.0% |
| Aug 12 | Raymond James | Downgrade | Outperform → Market Perform | — | $33.35 | $32.50 | -2.5% | -4.3% | -4.2% | +8.6% | -4.3% | -1.4% |
| Aug 12 | Barclays | Maintains | Overweight → Overweight | — | $33.35 | $32.50 | -2.5% | -4.3% | -4.2% | +8.6% | -4.3% | -1.4% |
| Mar 9 | Raymond James | Maintains | Outperform → Outperform | — | $22.07 | $23.00 | +4.2% | +5.0% | -0.9% | +2.6% | +1.3% | +0.5% |
| Aug 11 | Raymond James | Maintains | Outperform → Outperform | — | $17.35 | $17.54 | +1.1% | +1.0% | +1.7% | -0.9% | -2.4% | -1.9% |
| May 26 | Sidoti & Co. | Maintains | Buy → Buy | — | $17.21 | $18.00 | +4.6% | +3.2% | +3.7% | -4.4% | -3.2% | -0.6% |
| Feb 21 | Sidoti & Co. | Maintains | Buy → Buy | — | $22.94 | $23.02 | +0.3% | +0.7% | -0.7% | -4.7% | +0.8% | -4.4% |
| Dec 2 | Sidoti & Co. | Maintains | Buy → Buy | — | $19.16 | $19.42 | +1.4% | +3.4% | +2.4% | -4.2% | +0.8% | +0.4% |
| Nov 13 | Sidoti & Co. | Maintains | Buy → Buy | — | $15.53 | $15.64 | +0.7% | +1.8% | +0.4% | +13.4% | -1.0% | -1.3% |
| Nov 13 | Raymond James | Maintains | Outperform → Outperform | — | $15.53 | $15.64 | +0.7% | +1.8% | +0.4% | +13.4% | -1.0% | -1.3% |
| Mar 15 | Raymond James | Downgrade | Strong Buy → Outperform | — | $15.86 | $15.43 | -2.7% | -3.8% | -3.5% | -3.3% | -2.5% | -2.3% |
| Mar 14 | Raymond James | Downgrade | Strong Buy → Buy | — | $12.65 | $13.05 | +3.2% | +2.4% | -1.5% | -2.4% | +2.4% | +3.5% |
| Aug 22 | Jefferies | Upgrade | Hold → Buy | — | $8.60 | $9.00 | +4.7% | +14.8% | -4.8% | +4.3% | -1.0% | +1.0% |
| Nov 9 | Craig-Hallum | Downgrade | Buy → Hold | — | $6.80 | $5.67 | -16.7% | -5.9% | +3.9% | +2.3% | -2.9% | -3.0% |
| Jun 2 | Sterne Agee CRT | Maintains | Neutral → Neutral | — | $5.23 | $5.14 | -1.7% | +4.2% | -3.5% | +1.5% | +0.4% | +0.7% |
| Apr 15 | Sidoti & Co. | Maintains | Buy → Buy | — | $4.96 | $4.98 | +0.4% | +0.8% | +3.2% | +0.0% | +3.3% | +1.3% |
| Mar 15 | Jefferies | Maintains | Hold → Hold | — | $5.53 | $5.40 | -2.4% | -4.9% | +2.5% | -3.3% | +1.0% | -4.6% |
| Mar 26 | B. Riley FBR | Maintains | Buy → Buy | — | $7.77 | $8.16 | +5.0% | +5.7% | +0.2% | +3.0% | -0.9% | +3.3% |
No insider trades available.
8-K · 7.01
! Medium
RadNet, Inc. -- 8-K 7.01: Regulation FD Disclosure
RadNet acquired French AI medical imaging company Gleamer for approximately €230 million through its subsidiary, expanding its diagnostic capabilities internationally.
Mar 2
8-K
RadNet, Inc. -- 8-K Filing
RadNet reported strong fourth-quarter 2025 results across its 418 imaging centers, with management expressing satisfaction with operational performance and positioning for continued growth.
Mar 2
Data updated apr 26, 2026 10:14pm
· Source: massive.com